Health Care

Democrats pressed for changes Tuesday to a $6.3 billion medical research bill as Republican leaders prepared to try pushing the measure through the lame-duck Congress by next week.

The Environmental Protection Agency has released a list of toxic chemicals that will be the first reviewed under a recently enacted law that gives regulators increased authority to ban substances shown to endanger human health.

Nissan is going to offer internet access, safety technology and myriad accessory options the Japanese automaker calls "hyper-personalization," not only in new models but also for vehicles people already own.

Doctors warn that with no cure or prevention treatments available, millennials should be just as concerned about the disease as older adults.

Massachusetts Sen. Elizabeth Warren says a bill providing extra money for medical research is "extortion" and a giveaway to big biomedical companies.

Newly unsealed court testimony shows revealing new details about a rift that is highly unusual for two companies pressing ahead with a merger request.

UnitedHealth is backing its 2016 financial guidance and expects growth into 2017, with earnings per share potentially reaching $9.60.

UnitedHealth Group gave investors an early holiday gift.

The cannabis industry has been growing drastically in the past five years, with revenue expected to hit $6.7 billion in 2016.

President Barack Obama took on the problems of a lack of access to health care and high cost, but he and Democrats paid a political price.

U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover.

The latest on developments in financial markets (All times local): 9:35 a.m.

Kia is recalling nearly 72,000 SUVs in the U.S. because an electrical short in a computer can cause engine fires.

Juno Therapeutics Inc said two more patients had died after suffering brain swelling during a trial of its experimental genetically engineered leukemia drug, bringing the total up to five.

Shares of banks, industrials and health-care companies propelled the Dow Jones Industrial Average to 19000 on Tuesday.

Eli Lilly's experimental drug solanezumab failed to slow loss of cognitive ability in patients with mild Alzheimer's disease in a large trial.

Medtronic PLC (MDT) on Tuesday reported fiscal second-quarter net income of $1.12 billion.